ARMI | BioFabUSA will attend RAPID + TCT 2026, North America’s largest and most influential additive manufacturing event, taking place April 14–16 in Boston, MA. This event brings together innovators, engineers, and industry leaders exploring the frontiers of 3D printing, prototyping, and scalable production.
Additive manufacturing plays an increasingly vital role in the future of biomanufacturing. At RAPID + TCT 2026, ARMI will join peers in discovering how emerging 3D technologies can support regenerative medicine and personalized healthcare applications.
ARMI’s participation in RAPID reflects our commitment to integrating additive technologies into the regenerative medicine ecosystem. With applications ranging from engineered tissues to bioreactor components, additive tools offer unmatched potential for flexibility, customization, and speed in product development.
By attending this event, ARMI aims to:
This engagement aligns with ARMI’s mission to modernize manufacturing infrastructure and enable the rapid scaling of regenerative technologies.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
